Aeolus Pharmaceuticals Inc (AOLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 03-2006 | 12-2005 | 09-2005 | 06-2005 | 03-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,362 | -1,523 | -6,905 | -5,253 | -3,616 |
| Depreciation Amortization | N/A | N/A | 9 | 8 | 5 |
| Accounts receivable | 9 | N/A | 124 | 9 | 125 |
| Other Working Capital | 222 | 754 | -386 | -497 | -587 |
| Other Operating Activity | -646 | -156 | 316 | 379 | -41 |
| Operating Cash Flow | $-2,777 | $-925 | $-6,842 | $-5,354 | $-4,114 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | 25 | N/A | N/A |
| Investing Cash Flow | $N/A | $N/A | $25 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 42 | 21 | 62 | N/A | N/A |
| Other Financing Activity | 2,413 | 2,413 | 0 | 0 | 0 |
| Financing Cash Flow | $2,455 | $2,434 | $62 | $N/A | $N/A |
| Beginning Cash Position | 626 | 626 | 7,381 | 7,381 | 7,381 |
| End Cash Position | 304 | 2,135 | 626 | 2,027 | 3,267 |
| Net Cash Flow | $-322 | $1,509 | $-6,755 | $-5,354 | $-4,114 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,777 | -925 | -6,842 | -5,354 | -4,114 |
| Free Cash Flow | -2,777 | -925 | -6,842 | -5,354 | -4,114 |